CIS-imidazoles

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S252140, C514S326000, C514S399000, C544S122000, C544S370000, C546S210000, C548S334100

Reexamination Certificate

active

07132421

ABSTRACT:
The present invention provides compounds according to formula I and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity

REFERENCES:
patent: 6593353 (2003-07-01), Gudkov et al.
patent: 6734302 (2004-05-01), Kong et al.
patent: 363 061 (1990-04-01), None
patent: 433 682 (1991-06-01), None
patent: WO 00/78725 (2000-12-01), None
patent: WO 03/051359 (2003-06-01), None
patent: WO 03/051360 (2003-06-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

CIS-imidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CIS-imidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CIS-imidazoles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3661888

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.